Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
600329
Κατάταξη σε μετοχές
#4374
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, along with its... Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, along with its subsidiaries, primarily manufactures and markets traditional Chinese medicine, Western pharmaceuticals, and various healthcare products within the People's Republic of China. Its business activities are structured into two distinct divisions: Chinese Medicine and Western Medicine. The company's operations extend beyond its core offerings to include the production and distribution of Chinese, Western, and biological pharmaceutical items. It also engages in the wholesale and retail trade of medicines, biochemical pharmaceutical products, and everyday consumer goods, in addition to managing hospitals. Furthermore, Tianjin Pharmaceutical Da Ren Tang provides a comprehensive suite of services such as logistics, inventory management, equipment installation, and drug processing. It also offers pharmaceutical inspection, testing, and advisory services. In terms of its commercial model, the company supplies its proprietary branded medicinal products directly to wholesalers. Conversely, it acquires pharmaceuticals marketed under other brands from distributors, subsequently reselling these to other wholesale clients. Established in 1992 and based in Tianjin, People's Republic of China, the company was previously known as Tianjin Zhong Xin Pharmaceutical Group Corporation Limited before adopting its current name in May 2022.
Τιμή μετοχής
$6.17
Κεφαλαιοποίηση
$3.52B
Αλλαγή (1 ημέρα)
-0.05%
Αλλαγή (1 έτος)
-1.86%
Χώρα
CN
Εμπόριο Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (600329)
Κατηγορία
Healthcare
Αριθμός κυκλοφορούντων μετοχών για Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (600329)
Αριθμός κυκλοφορούντων μετοχών στις October 2026: 0
Σύμφωνα με τις τελευταίες οικονομικές αναφορές και την τιμή μετοχής της Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, ο τρέχων αριθμός κυκλοφορούντων μετοχών είναι 0. Στο τέλος του October 2026, η εταιρεία είχε 0 κυκλοφορούντες μετοχές. Ο αριθμός των κυκλοφορούντων μετοχών επηρεάζεται συνήθως από διασπάσεις μετοχών και επαναγορές.
Ιστορικό κυκλοφορούντων μετοχών για Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (600329) από 2001 έως 2026
Κυκλοφορούντες μετοχές στο τέλος κάθε έτους
| Έτος | Κυκλοφορούντες μετοχές | Αλλαγή |
|---|---|---|
| 2025 | 769.32M | -0.11% |
| 2024 | 770.16M | -0.09% |
| 2023 | 770.87M | 0.26% |
| 2022 | 768.87M | 0.00% |
| 2021 | 768.87M | 0.00% |
| 2020 | 768.87M | 0.00% |
| 2019 | 768.87M | 0.00% |
| 2018 | 768.87M | 0.13% |
| 2017 | 767.87M | -0.13% |
| 2016 | 768.87M | 2.19% |
| 2015 | 752.40M | 0.94% |
| 2014 | 745.42M | 1.71% |
| 2013 | 732.90M | -0.35% |
| 2012 | 735.50M | -1.99% |
| 2011 | 750.45M | 2.35% |
| 2010 | 733.22M | -0.46% |
| 2009 | 736.62M | 0.37% |
| 2008 | 733.90M | -0.34% |
| 2007 | 736.38M | 0.01% |
| 2006 | 736.29M | 0.00% |
| 2005 | 736.29M | 0.00% |
| 2004 | 736.29M | 0.00% |
| 2003 | 736.29M | 0.00% |
| 2002 | 736.29M | 0.00% |
| 2001 | 736.29M | 0.00% |
Κυκλοφορούντες μετοχές για παρόμοιες εταιρείες ή ανταγωνιστές
| Εταιρεία | Κυκλοφορούντες μετοχές | Διαφορά | Χώρα |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 2.40B | - |
IN
|
